Copyright
©The Author(s) 2020.
World J Gastrointest Pathophysiol. Mar 13, 2020; 11(1): 1-19
Published online Mar 13, 2020. doi: 10.4291/wjgp.v11.i1.1
Published online Mar 13, 2020. doi: 10.4291/wjgp.v11.i1.1
Figure 7 Gross presentation of lesions (C) and lesions attenuation (B) in rats with suprahepatic occlusion of inferior vena cava.
Lesions were assessed using a camera attached to a USB microscope (Veho Discovery Deluxe VMS-004), at 15 min (upper, a), 24 h (middle, b), and 48 h (low, c) post-ligation in the gastrointestinal tract. From left to right, the stomach, duodenum, jejunum, ileum, cecum and ascending colon on treatment with saline (C) or BPC 157 (B).
- Citation: Gojkovic S, Krezic I, Vrdoljak B, Malekinusic D, Barisic I, Petrovic A, Horvat Pavlov K, Kolovrat M, Duzel A, Knezevic M, Kasnik Kovac K, Drmic D, Batelja Vuletic L, Kokot A, Boban Blagaic A, Seiwerth S, Sikiric P. Pentadecapeptide BPC 157 resolves suprahepatic occlusion of the inferior caval vein, Budd-Chiari syndrome model in rats. World J Gastrointest Pathophysiol 2020; 11(1): 1-19
- URL: https://www.wjgnet.com/2150-5330/full/v11/i1/1.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v11.i1.1